# Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study

> **NCT02023788** · — · COMPLETED · sponsor: **Medipost Co Ltd.** · enrollment: 8 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia
- Respiratory Tract Infections
- Premature Birth of Newborn

## Interventions

- **BIOLOGICAL:** PNEUMOSTEM

## Key facts

- **NCT ID:** NCT02023788
- **Lead sponsor:** Medipost Co Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2018-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02023788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02023788, "Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02023788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*